| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/23/2001 | EP1100943A2 Herpesviral vectors for gene delivery |
| 05/23/2001 | EP1100942A2 Herpes virus vectors for dendritic cells |
| 05/23/2001 | EP1100941A2 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 05/23/2001 | EP1100921A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/23/2001 | EP1100920A2 Nucleic acids and proteins from group b streptococcus |
| 05/23/2001 | EP1100918A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/23/2001 | EP1100916A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 05/23/2001 | EP1100914A2 Novel genes in control of hematopoiesis |
| 05/23/2001 | EP1100913A1 Mekk1 serine threonine kinases -interacting fha forkhead associated domain protein 1 (mif1) |
| 05/23/2001 | EP1100910A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 05/23/2001 | EP1100908A2 Human receptor-associated proteins |
| 05/23/2001 | EP1100906A1 Kdel receptor inhibitors |
| 05/23/2001 | EP1100905A2 Human epidermal proteins hepi-1 to hepi-6 |
| 05/23/2001 | EP1100901A1 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 05/23/2001 | EP1100896A1 Dna encoding snorf33 receptor |
| 05/23/2001 | EP1100895A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 05/23/2001 | EP1100894A2 Short oligonucleotides for the inhibition of vegf expression |
| 05/23/2001 | EP1100892A1 Use of prohibitin rna in treatment of cancer |
| 05/23/2001 | EP1100887A1 Growth differentiation factor-11 |
| 05/23/2001 | EP1100886A1 Tumor necrosis factor-gamma |
| 05/23/2001 | EP1100882A1 Human protein kinase h2lau20 |
| 05/23/2001 | EP1100880A2 Urate oxidase |
| 05/23/2001 | EP1100879A1 Pneumococcal nrdg protein |
| 05/23/2001 | EP1100878A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 05/23/2001 | EP1100869A1 98 human secreted proteins |
| 05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
| 05/23/2001 | EP1100825A1 Human mink gene mutations associated with arrhythmia |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100817A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100548A2 Genetically engineered cells and tissues |
| 05/23/2001 | EP1100547A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 05/23/2001 | EP1100546A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| 05/23/2001 | EP1100545A1 Regulated expression of recombinant proteins using rna viruses |
| 05/23/2001 | EP1100538A2 Kvlqt1 - a long qt syndrome |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100464A1 Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| 05/23/2001 | EP1100462A2 Methods of ophthalmic administration |
| 05/23/2001 | EP0215907B1 Parasite-derived resistance |
| 05/23/2001 | DE19956029A1 Active substance carrier system based on coating a substance with enzymatically cleavable side groups, useful for gene therapy especially of cancer and inflammation |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235968 Detecting angiogenesis |
| 05/22/2001 | US6235967 Metastasis models using green fluorescent protein as a marker |
| 05/22/2001 | US6235879 Apoptosis modulators that interact with the Huntington's disease gene |
| 05/22/2001 | US6235878 Apoptosis induction |
| 05/22/2001 | US6235872 Genetic engineering |
| 05/22/2001 | US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression |
| 05/22/2001 | US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235523 Vector having nucleic acid encoding a human papillomavirus-16 e7 antigen lacking the rb protein binding site and operably linked to a cytomegalo virus promoter; vaccines |
| 05/22/2001 | US6235522 Lentiviral vectors |
| 05/22/2001 | US6235497 Viral vector coding rodent transport protein; for treatment of nervous system disorders |
| 05/22/2001 | US6235285 An isolated polypeptide comprising a heterologous amino acid sequence fused to specific polynucleotide sequence |
| 05/22/2001 | US6235224 Dissolving polymer in solvent, dissolving or dispersing agent to be encapsulated in said solvent, introducing mixture into nonsolvent to cause spontaneous formation of microencapsulated product |
| 05/17/2001 | WO2001035102A2 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | WO2001034843A1 Lentiviral vector transduction of hematopoietic stem cells |
| 05/17/2001 | WO2001034827A1 Antisense modulation of rank expression |
| 05/17/2001 | WO2001034809A2 Staphylococcus epidermidis nucleic acids and proteins |
| 05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034801A2 Recombinant gelatin in vaccines |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034793A1 Method of effecting dna splicing |
| 05/17/2001 | WO2001034781A2 Lytic enzymes useful for treating fungal infections |
| 05/17/2001 | WO2001034775A1 Mesenchymal stem cells and/or progenitor cells, their isolation and use |
| 05/17/2001 | WO2001034774A2 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 05/17/2001 | WO2001034771A2 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034769A2 24 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034649A2 Compositions and methods for treating autoimmune diseases and transplant rejections |
| 05/17/2001 | WO2001034646A2 Recombinant gelatins |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034630A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034626A1 28 human secreted proteins |
| 05/17/2001 | WO2001034625A1 Isolation and characterization of human nf-e4 |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034208A1 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 05/17/2001 | WO2001034207A1 Gene carriers |
| 05/17/2001 | WO2001034206A2 Nucleic acid-containing complex |
| 05/17/2001 | WO2001034205A2 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | WO2001034185A2 Induction of mucosal immunity by vaccination via the skin route |
| 05/17/2001 | WO2001034179A1 Method of inducing angiogenesis |
| 05/17/2001 | WO2001034173A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001034167A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | WO2001034130A1 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 05/17/2001 | WO2001033965A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001033964A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME 18q RELATED DISORDERS |
| 05/17/2001 | WO2001023577A3 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences |
| 05/17/2001 | WO2001018043A3 Neurogenic compositions and methods |